Longboat offers an internally developed platform for clinical trial management. The platform includes a range of modules for different parts of the clinical trial process, including patient recruitment and screening, patient-reported outcomes, electronic consent, payments, source data capture, and return on investment analysis. The platform is compliant with 21 CFR Part 11 and simplifies compliance-related tasks for the research team and sponsor.
Key customers and partnerships
Its key clients include Moderna, Parexel, Sarepta Therapeutics, Ipsen, and Ferring Pharmaceuticals. As of May 2022, the platform was used by over 13,000 research sites located across 63 countries.
Funding and financials
Longboat was acquired by Advarra in late 2020 to supplement the acquirer’s offerings in the regulatory review and clinical site tech space.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.